Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Today, the Ted Rogers Centre turns four years old.
On Nov. 20, 2014, the largest gift in Canadian health-care history was announced, and our promise of a healthy heart was born. The Rogers family gift is a testament to Ted Rogers’ drive for innovation and commitment to leaving the world a better place. Ted passed away from heart failure — a disease of epidemic proportions that is the focus of our Centre — in 2008 at the age of 75.
Four years ago there was no precision medicine program to better understand the genetic basis of heart failure in specific patient populations… no cardiac genome project to sequence genomes of entire families who live with the disease… no integrated research labs dedicated to translating engineering science into regenerative techniques for restoring a heart’s function… no major annual event that united such a diverse group of experts and trainees toward one goal… no mobile health platforms that provide seamless monitoring and transfer of care for patients with heart failure… and no dedicated, technology-driven efforts to keep people with heart failure out of hospital and safe.
While it took time to get such collaborative work underway, the Ted Rogers Centre is now poised for dramatic breakthroughs in many areas. We can’t wait to unveil the results in coming months and years and provide patients and families with ever more reasons for hope.
